Co-Occurrence of High-Risk Lesions Is a Consistent Predictor of Ultra-High Risk Multiple Myeloma in Newly Diagnosed and Relapsed/Refractory Patients - Meta-Analysis of 5,808 Trial Patients
Martin Kaiser(Royal Marsden NHS Foundation Trust), Francesca Gay(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Mario Boccadoro(University of Turin), Alessandra Larocca(Cornell University), Gordon Cook(University of Leeds), David A. Cairns(BMW (Germany)), Pellegrino Musto(University of Bari Aldo Moro), Niels Weinhold(German Cancer Research Center), Hartmut Goldschmidt(Heidelberg University), Kwee Yong(CRUK Lung Cancer Centre of Excellence), Marc S. Raab(Unknown), Sarah Brown(University of Leeds), Marc-A. Baertsch(Heidelberg University), Graham Jackson(Newcastle College), Pieter Sonneveld(Erasmus MC Cancer Institute), Cong Li, Andréa Capra
Cited by 10
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k